|CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368|
September 07, 2016
Health Tip: Protect Skin From Diabetes
(HealthDay News) -- Skin problems are common in people with diabetes, but a good daily skin-care routine may offer some protection.
Health Tip: Preventing Summertime Dry Skin
(HealthDay News) -- Hot weather, swimming and more time spent outside can lead to dry skin.
'Glycemic Index' May Be Too Unreliable to Manage Diabetes: Study
WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- Glycemic index values of the same foods can vary widely and may be an unreliable indicator of blood sugar response, according to a new study.
TV Booze Ads a Lubricant for Teen Drinking: Study
WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- The more ads for a brand of alcohol that underage drinkers see, the more likely they are to consume that product, a new study finds.
Hair Plus DNA May Advance Forensics
WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- Certain proteins in the hair can be used alongside DNA in forensics and archeology, researchers report.
Heart Rhythm Disorder May Be Tied to Wider Range of Ills
WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- Atrial fibrillation, a common type of heart rhythm disorder, is associated with a wider range of conditions than previously believed, researchers report.
Delivering Twins at 37 Weeks May Help Prevent Stillbirths
WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- A woman carrying twins should deliver her babies at 37 weeks to reduce the risk of stillbirth and newborn death, new research says.
New Biologic Drug Tackles Hard-to-Control Asthma
WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- A new injectable drug reduces flare-ups in patients with severe asthma that is not controlled by steroid inhalers alone, two new trials show.
Are Birth Control Pills Tied to Decline in Ovarian Cancer Deaths?
WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- Ovarian cancer deaths are down dramatically in many parts of the world, and researchers believe the use of birth control pills may be a main reason why.
For Those With Sleep Apnea, Maybe It's Time for a Driving Test
TUESDAY, Sept. 6, 2016 (HealthDay News) -- Erratic driving may be a problem for people with sleep apnea.
Intensive Type 2 Diabetes Treatment Can Extend Survival: Study
WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- Intensive management of type 2 diabetes can make a difference in how long and how well you live, even if you don't start until middle age, researchers report.
Cord-Blood Transplants Show Promise in Leukemia Treatment
WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- Bone marrow or stem cell transplants can save the lives of adults and children with leukemia, but an ideal donor often isn't available. In those cases, umbilical cord blood may work as well as current alternatives -- or even better in some cases, a new study suggests.
Congress Can't Agree on Additional Funding to Fight Zika
WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- Congress returned to work Tuesday from its seven-week summer break and failed to agree on additional funding to fight the Zika virus.
Stroke Survivors Often Struggle With Depression
WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- Stroke survivors face an increased risk of developing depression, a new study suggests.
A Woman's Weight Has Complex Link to Stroke Risk
WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- Excess weight may put women at increased risk for the most common form of stroke, but at lower risk for a less common stroke type, new research shows.
Health Highlights: Sept. 7, 2016
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Do Overweight People Fare Better Than Others With Kidney Cancer?
WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- Obesity is a risk factor for kidney cancer. Yet, obese people with advanced kidney cancer seem to live longer than normal-weight or underweight patients, a new study finds.
Immune-Based Drug May Ease Chronic Eye Condition
WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- People with chronic eye inflammation known as uveitis may be able to keep the condition at bay with the immune-suppressing drug Humira (adalimumab), a new study finds.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.